Pioglitazone in Early Parkinson's Disease

NCT01280123 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

210

Enrollment

OTHER

Sponsor class

Conditions

Parkinson's Disease

Interventions

DRUG: Pioglitazone
DRUG: placebo

Sponsor

University of Rochester

Collaborators

[object Object]
[object Object]